Chief Technical Officer
Mon, Sep 18, 2023
Sep 18
exercised or converted securities in APLS
9,719 shares @ $0.00
Decreased holdings by -7.80%
Option Exercise
Sale tied to a same-time option exercise
APLSApellis Pharmaceuticals, Inc.
HealthcareBiotechnology